| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 804-813, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
Y Tsutsui, A Kashiwai, N Kawamura and C Kadota
Department of Pathology, Aichi Prefectural Colony, Japan.
Microphthalmia and cerebral atrophies were induced in mouse embryos after injection of murine cytomegalovirus (MCMV) into the conceptus at midgestation. The concepti of ICR mice on day 8.5 of gestation were injected with MCMV through the uterine wall, then pregnancies were allowed to continue. On day 15.5 of gestation, microphthalmia was observed in 19.2% of the MCMV-injected embryos (1 x 10(4) plaque- forming units). As the survival rate decreased when pregnancies were allowed to continue further, incidence of microphthalmia decreased, whereas cerebral atrophies, determined by examining the histological sections, were observed in 17.6% of the surviving mouse fetuses on day 18.5 of gestation. Microphthalmia was confirmed by microscopically measuring the eyes on the serial coronal sections. There were two types of microphthalmia: one with marked hypoplastic eye with periglobular mesenchymal proliferation, the other with small eye and lens without the mesenchymal proliferation. Immunohistochemical analysis was performed using antibodies specific to the nuclear antigen of MCMV. Viral antigen-positive cells were widely distributed in the mesenchymes around the oral and nasal cavities and in the mesenchymes around the brain, especially in the endothelial cells of the vessels and the perivascular mesodermal cells. In the eyes, viral antigen-positive cells were observed in mononuclear blood cells in the cavities of the vitreous bodies. These results suggest that the primary target of congenital cytomegalovirus infection may be the mesenchymal cells; then the infection extends to the eyes and brain. In addition, the mesenchymal infection may also disrupt their organogenesis, resulting in microphthalmia and cerebral atrophy. This experimental system may provide a model similar to congenital cytomegalovirus infection in humans.
This article has been cited by other articles:
![]() |
Y. Arai, M. Ishiwata, S. Baba, H. Kawasaki, I. Kosugi, R.-Y. Li, T. Tsuchida, K. Miura, and Y. Tsutsui Neuron-Specific Activation of Murine Cytomegalovirus Early Gene e1 Promoter in Transgenic Mice Am. J. Pathol., August 1, 2003; 163(2): 643 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kosugi, H. Kawasaki, Y. Arai, and Y. Tsutsui Innate Immune Responses to Cytomegalovirus Infection in the Developing Mouse Brain and Their Evasion by Virus-Infected Neurons Am. J. Pathol., September 1, 2002; 161(3): 919 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsutsui, H. Kawasaki, and I. Kosugi Reactivation of Latent Cytomegalovirus Infection in Mouse Brain Cells Detected after Transfer to Brain Slice Cultures J. Virol., June 14, 2002; 76(14): 7247 - 7254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aiba-Masago, S. Baba, R.-Y. Li, Y. Shinmura, I. Kosugi, Y. Arai, M. Nishimura, and Y. Tsutsui Murine Cytomegalovirus Immediate-Early Promoter Directs Astrocyte-Specific Expression in Transgenic Mice Am. J. Pathol., March 1, 1999; 154(3): 735 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhu, J.-P. Cong, G. Mamtora, T. Gingeras, and T. Shenk Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays PNAS, November 24, 1998; 95(24): 14470 - 14475. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |